De la Torre, A., & Ramírez Ibarguen, A.-F. (2024). Minimal Residual Disease in Myeloma in 2024: Where We are Today. Canadian Hematology Today, 3(3), 47–54. https://doi.org/10.58931/cht.2024.3360